Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Indy Hematology Review

C. Kessler

Evolving Treatment Landscape in ITP

Robert Bird

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Current Management of Accelerated/Blast-Phase MPNs

UChicago Medicine

A. Patel

ACP 2024 Insights: Sickle Cell Anemia - Diagnosis and Management of …

Insights from 2024 ACP Annual Meeting

M. Okam Achebe

Role of Antiplatelet and Anticoagulant Therapy: Managing Vaso-Occlus…

Erica Sparkenbaugh

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

Nirmish Shah

Gene Therapy for Sickle Cell Disease: Are We Where They Wanted Us to…

Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

A. Sharma

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

Risk for Developing VTE in Pts With Compound Heterozygosity of FVL a…

Cleveland Clinic Taussig Cancer Institute

G. Gerber

Sickle Cell Disease 101

Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

I. Osunkwo

Hematologic Emergencies

Michigan Medicine

A. Ahmed

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Yale Cancer Center

J. Ryu

Updates in Therapeutics for Sickle Cell Disease

University of Colorado Division of Hematology

G. George

ASH 2023 Summary: "Updates in Hereditary TTP and Sickle Cell Disease"

BMFcases

I. Ibrahim, T. Bat, Y. Shen

ATS 2023 Insights: Airway Function in Sickle Cell Disease: Impact on…

ATS 2023 Insights

S. Willen